1 withdrawn. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Devic's Disease: new trials by email Literature Review of Devic's Disease trials Research Report on Devic's Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autologous Transplant To End NMO Spectrum Disorder Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease | Phase 2 / Phase 3 | Withdrawn | Northwestern University | 2019-11-01 | 2019-11-20 |
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Cranial Nerve Diseases (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Eye Diseases (1) · Immune System Diseases (1) · Myelitis, Transverse (1) · Nervous System Diseases (1) · Optic Nerve Diseases (1) · Optic Neuritis (1)
Antilymphocyte Serum (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Immunoglobulin G (1) · Immunoglobulins, Intravenous (1) · Mesna (1) · Methylprednisolone (1) · Methylprednisolone Acetate (1) · Methylprednisolone Hemisuccinate (1) · Octagam (1) · Rituximab (1) · thymoglobulin (1)
United States (1)
Richard Burt, MD (1)